Molecular Multispeciality Hospitals Private Limited, a active private limited company, was established on 07 February 2013 in Trichur, Kerala, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85110KL2013PTC033263. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹7.00 Cr and a paid-up capital of ₹6.60 Cr.
It upholds a compliant status. Its leadership includes Mibu Jose (Director), Chirayath Paulson Varkey (Managing Director), Kizhakkebhagathu Ajith Joy (Managing Director). It holds ₹3.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Viii/843, Ceeveesadan, Chirayath House Ancherichira P O, Trichur, Kerala, 680006.
U85110KL2013PTC033263
033263
07 February 2013
₹7.00 Cr
₹6.60 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Molecular Multispeciality Hospitals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mibu Jose | Director | 07 Feb 2013 | Current |
| Chirayath Paulson Varkey | Managing Director | 07 Feb 2013 | Current |
| Kizhakkebhagathu Ajith Joy | Managing Director | 07 Feb 2013 | Current |
| Methale Purayil Hassan Kunhi | Director | 07 Feb 2013 | Current |
| Mathew Francis Kattukkaran | Director | 07 Feb 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Molecular Multispeciality Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 34.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Molecular Multispeciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2016 | Others | ₹3.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Molecular Multispeciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Molecular Multispeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Multispeciality Hospitals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Molecular Multispeciality Hospitals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Molecular Multispeciality Hospitals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100026578 was registered on 19 Apr 2016. was completed.
Progress on Mibu Jose was appointed as a Director was appointed as a Director on 07 Feb 2013 & has been associated with this company since 12 years 11 months . was documented.
Chirayath Paulson Varkey was appointed as a Managing Director was appointed as a Managing Director on 07 Feb 2013 & has been associated with this company since 12 years 11 months . was recorded as a recent event.
The activity Kizhakkebhagathu Ajith Joy was appointed as a Managing Director was appointed as a Managing Director on 07 Feb 2013 & has been associated with this company since 12 years 11 months . was completed.
The CIN of Molecular Multispeciality Hospitals Private Limited is U85110KL2013PTC033263.
Molecular Multispeciality Hospitals Private Limited is headquartered at Viii/843, Ceeveesadan, Chirayath House Ancherichira P O, Trichur, Kerala, 680006.
Molecular Multispeciality Hospitals Private Limited was incorporated on 07 February 2013.
The current directors of Molecular Multispeciality Hospitals Private Limited are
The primary industry of Molecular Multispeciality Hospitals Private Limited is Hospital And Medical Care.
Molecular Multispeciality Hospitals Private Limited is unlisted.
The authorized capital of Molecular Multispeciality Hospitals Private Limited is ₹7.00 Cr, and the paid-up capital is ₹6.60 Cr.
The compliance status of Molecular Multispeciality Hospitals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX